Purchase
Description
CYRAMZA (ramucirumab) is a recombinant human IgG1 monoclonal antibody that specifically binds to vascular endothelial growth factor receptor 2. ramucirumab has an approximate molecular weight of 147 kDa. ramucirumab is produced in genetically engineered mammalian CHO cells.
Ramucirumab is supplied at a concentration of 10 mg/mL as a sterile, preservative-free, clear to slightly opalescent and colorless to slightly yellow solution of pH 6.0, which contains 9.98 mg/mL glycine, 0.65 mg/mL histidine, 1.22 mg/mL histidine monohydrochloride, 0.1 mg/mL polysorbate 80, 4.383 mg/mL sodium chloride, and Water for Injection.
Properties
|
Name
|
Ramucirumab
|
|
CAS
NO.
|
947687-13-0
|
|
Type
|
Whole
antibody
|
|
Source
|
Human
|
|
Target
|
VEGFR2 (KDR)
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
147 kDa
|
|
Formula
|
C6374H9864N1692O1996S46
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Place
of Origin
|
China (Mainland)
|
|
Storage
|
-70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154973077307.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Ramucirumab
|
